Betamethasone sodium Phosphate content not less than 96.0% and not more than 103.0% of C22H28FNa2O8P, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

磷酸納貝皮質醇
Betamethasone Sodium Phosphate

• 申請商: 溫帝國際有限公司
• 適應症: 抗炎性皮質醇
• 發證日期: 2020-09-07